Shoji Kume

1.8k citations
34 papers · 1.5k indexed · 1 hit paper · h-index 15
Topics
Platelet Disorders and Treatments (6 papers)Sphingolipid Metabolism and Signaling (5 papers)S100 Proteins and Annexins (5 papers)
Partner nations
JapanUnited StatesPoland

In The Last Decade

Shoji Kume

34 papers receiving 1.4k citations

Hit Papers

Activation by Adenosine Triphosphate in the Phosphorylati...19722026199020081972200400600

Peers

Shoji Kume
Comparison fields: 5 of 103
  • Molecular Biology 1.0k
  • Cell Biology 186
  • Immunology 133
  • Hematology 125
  • Physiology 120
Replace N. Crawford with:
N. Crawford United Kingdom
George B. Zavoico United States
Masood N. Khan Canada
Suresh B. Chahwala United States
M. Lenfant France
Jinghua Yu China
Barry R. Ganong United States
Ronald P. Magnusson United States
Laura Fiorucci Italy
Shoji Kume relative to N. Crawford United Kingdom N. Crawford's profile →
Citations per field
00.5×1.5×2.1×
N. Crawford · 1×
Citations per year

Countries citing papers authored by Shoji Kume

Since Specialization
Citations

This map shows the geographic impact of Shoji Kume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoji Kume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoji Kume more than expected).

Fields of papers citing papers by Shoji Kume

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoji Kume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoji Kume. The network helps show where Shoji Kume may publish in the future.

Co-authorship network of co-authors of Shoji Kume

This figure shows the co-authorship network connecting the top 25 collaborators of Shoji Kume. A scholar is included among the top collaborators of Shoji Kume based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoji Kume. Shoji Kume is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 10
3 6
4 1
5 20
6 25
7 18
8 11
9 28
10 13
11 9
12 7
13 59
14 9
15 5
16 14
17 26
18 7
19 3
20 4

About Shoji Kume

Shoji Kume is a scholar working on Hematology, Immunology and Allergy and Microbiology, having authored 34 papers that have together received 1.5k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (6 papers), Sphingolipid Metabolism and Signaling (5 papers) and S100 Proteins and Annexins (5 papers). The work is most often cited by research in Molecular Biology (1.0k citations), Cell Biology (186 citations) and Hematology (125 citations). Shoji Kume has collaborated with scholars based in Japan, United States and Poland. Frequent co-authors include Robert L. Post, C Hegyváry, Yutaka Yatomi, Yukio Ozaki, Kaneo Satoh, Tatsuya Ōhashi, Yukio Ozaki, Yukio Ozaki, Yasuyuki Igarashi and Gábor Tigyi. Their work appears in journals such as Journal of Biological Chemistry, Blood and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026